Common Medical Food(MF) Products

Some examples of MFs are: special infant formulas, formulations for metabolic disorders, oral rehydration products or products for chronic diarrhea, and special nutritional formulas for patients with diabetes, AIDS, kidney disease, or inborn errors in metabolism. Traditional MFs are typically in the form of liquids or powdered drink mixes.

Below are just a few examples of traditional MF products currently on the market:

LIPISORB® - for nutritional management of AIDS patients with fat Malabsorption
NEPRO® - for people on dialysis with specific nutrient needs and altered metabolism
OXEPA® - for the dietary management of critically ill patients with lung injury
PERATIVE® - for metabolically stressed patients with pressure ulcers, multiple fractures, wounds, burns, or surgery who can benefit from supplemental arginine.
RENAX® - for the nutritional management of end stage renal Disease or renal Insufficiency
SUPLENA® - for people with chronic or acute kidney failure who are not receiving dialysis

Lipisorb® is a registered trademark for Novartis®. Nepro®, Oxepa®, Perative®, and Suplena® are registered rademarks of Abbott Laboratories®. Renax® is a registered trademark of Everett Laboratories.

There are also many MFs developed over the past few years that are available in pill, capsule, or tablet form. These products have developed as more and more diseases have been recognized as having a metabolic basis. In addition, new MF products are typically distributed through pharmacies, rather than in a hospital or institutional setting.

Below are a few examples of more recent MF products:

FOLGARD Rx® - for nutritional support and folic acid supplementation.
FOLTX® - for the distinct nutritional requirements of individuals under a physician's treatment for hyperhomocysteinemia, homocystinuria, or nutrient malabsorbtion; with particular emphasis for individuals with or at risk for: cardiovascular disease, peripheral vascular disease, arteriosclerotic vascular disease, and vitamin B12 deficiency.
PHLEXY-10® - for the management of phenylketonuria (PKU) in patients one year and older.
STROVITE FORTE® - for prophylactic or therapeutic nutritional management in physiologically stressful conditions.
ULTRASE® - for patients with partial or complete exocrine pancreatic insufficiency caused by: Cystic fibrosis, chronic pancreatitis due to alcohol use or other causes, surgery pancreatico-duodenectomy or Whipple's procedure, with or without Wirsung duct injection, total pancreatectomy), obstruction (pancreatic and biliary duct lithiasis, pancreatic and duodenal neoplasms, ductal stenosis), other pancreatic disease (hereditary, post traumatic and allograft pancreatitis, hemochromatosis, Shwachman's Syndrome, lipomatosis, hyperparathyroidism), poor mixing (Billroth II gastrectomy, other types of gastric bypass surgery, gastrinoma), pancrelipase capsules are effective in controlling steatorrhea.

Folgard Rx® is a registered trademark of Upsher-Smith. Foltx® is a registered trademark of Pan American Laboratories. Phlexy-10® is a registered trademark of SHS North America. Strovite Forte® is a registered trademark of Everett Laboratories. ULTRASE® is a registered trademark of Axcan Scandipharm Inc.